New hope for babies with leukemia: immunotherapy combo trial launches
NCT ID NCT05848687
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment plan for infants (up to 12 months old) with a type of leukemia called acute lymphoblastic leukemia. The goal is to see if adding an immunotherapy drug called blinatumomab can better clear leukemia cells that remain after initial treatment. About 90 babies will take part to find the safest and most effective doses.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE UNDIFFERENTIATED LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alberta Children's Hospital
NOT_YET_RECRUITINGCalgary, Alberta, T3B 6A8, Canada
-
Arkansas Children's Hospital
RECRUITINGLittle Rock, Arkansas, 72202, United States
-
Arnold Palmer Hospital for Children
RECRUITINGOrlando, Florida, 32806, United States
-
BC Children's Hospital
NOT_YET_RECRUITINGVancouver, British Columbia, V6H 3V4, Canada
-
CHU Sainte-Justine
NOT_YET_RECRUITINGMontreal, Quebec, H3T 1C5, Canada
-
Children's Hospital Los Angeles
RECRUITINGLos Angeles, California, 90027, United States
-
Children's Hospital of Minnesota
RECRUITINGMinneapolis, Minnesota, 55404, United States
-
Children's Hospital of Orange County
RECRUITINGOrange, California, 92868, United States
-
Children's Hospital of The King's Daughters
RECRUITINGNorfolk, Virginia, 23507, United States
Contact Email: •••••@•••••
-
Chu De Quebec
NOT_YET_RECRUITINGQuébec, Quebec, G1V 4G2, Canada
-
Doernbecher Children's Hospital
RECRUITINGPortland, Oregon, 97239, United States
-
MD Anderson
RECRUITINGHouston, Texas, 77030, United States
-
McMaster Children's Hospital
NOT_YET_RECRUITINGHamilton, Ontario, L8N 3Z5, Canada
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Montreal Children's Hospital
NOT_YET_RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Novant Health - Hemby Children's Hospital
NOT_YET_RECRUITINGCharlotte, North Carolina, 28204, United States
-
Penn State Milton S Hershey Medical Center
RECRUITINGHershey, Pennsylvania, 17033-0850, United States
-
Phoenix Children's Hospital
RECRUITINGPhoenix, Arizona, 85016, United States
-
Rady Children's Hospital San Diego
NOT_YET_RECRUITINGSan Diego, California, 92123, United States
-
Stanford University
RECRUITINGPalo Alto, California, 94304, United States
-
Stollery Children's Hospital
NOT_YET_RECRUITINGEdmonton, Alberta, T6G 2B7, Canada
-
University of Texas Health Science Center San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
University of Utah Huntsman Cancer Institute
RECRUITINGSalt Lake City, Utah, 84108, United States
-
Valley Children's Hospital
RECRUITINGMadera, California, 93636, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could bone marrow from deceased donors cure blood cancers?
- Lab-Grown stem cells could speed immune recovery in blood cancer transplants
- New transplant recipe aims to tame Graft-Versus-Host disease
- Selective immune cell removal may tame transplant complications
- New stem cell transplant method aims to cut complications in young blood cancer patients
- New study aims to stop blood cancer relapse after transplant